PaxMedica Accelerates RSU Vesting for Top Executives

PaxMedica, Inc. (PXMD) has released an update to notify the public and investors about its officers.

PaxMedica, Inc.’s Board approved the acceleration of vesting for certain restricted stock units (RSUs) to lessen administrative burdens. Key executives, including President and CEO Howard Weisman, CFO and COO Stephen Sheldon, and Chief Medical Officer Dr. David Hough, will benefit from this acceleration. The accelerated RSUs, whose values are based on the company’s closing stock price, will fully vest the day after the annual report is filed, contingent upon continued employment.

For further insights into PXMD corporate activity, check out TipRanks’ Insiders Trading Activity page.